Related Experiment Video
Updated: Mar 19, 2026
09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
3.6K
Delayed severe abciximab-induced thrombocytopenia: A case report
Łukasz Piątek1, Agnieszka Janion-Sadowska1, Jacek Kurzawski1
1Provincial Hospital Complex in Kielce, Department of Cardiology, 45 Grunwaldzka Street, 25-715 Kielce, Poland.
Heart & Lung : the Journal of Critical Care
|June 25, 2016
Summary
Abciximab-induced thrombocytopenia, a rare side effect in acute coronary syndrome patients, can be managed effectively. This case study shows a patient recovered well with platelet transfusions and dexamethasone.
Area of Science:
- Cardiology
- Hematology
Background:
- Thrombocytopenia is a known adverse effect of abciximab, a medication used for acute coronary syndromes (ACS).
- Diagnosis and management of abciximab-induced thrombocytopenia remain challenging.
Observation:
- A case of a 57-year-old male with ST-segment elevation ACS treated with abciximab is presented.
- Rapid and severe thrombocytopenia (1 × 10(9)/L) developed post-abciximab infusion.
Findings:
- The patient received platelet transfusions and intravenous dexamethasone.
- Dual antiplatelet therapy was maintained throughout the treatment course.
Implications:
- This case highlights a potential treatment approach for abciximab-induced thrombocytopenia.
- Further research into the mechanisms and standardized management of this condition is warranted.
More Related Videos
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
455
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
455
01:30Acute Coronary Syndrome I: Introduction
1.4K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K